Skip to content
Case report Open access

Phenotypic Evidence for the Reclassification of the RYR1 p.(Glu4410Asp) Variant: From Uncertain Significance to Likely Benign

Oct 2026 · Genes · Vol 17 · 0 citations · 21 references
Medicine

TL;DR

A 27-year-old African American female with a personal history of recurrent exertional rhabdomyolysis found to have a heterozygous RYR1 c.13230G>C p.(Glu4410Asp) variant is reported, which meets the ClinGen MHS Variant Curation Expert Panel (VCEP) criteria for reclassification of the variant to Likely Benign.

Abstract

Malignant Hyperthermia Susceptibility (MHS) is most commonly caused by pathogenic variants in the RYR1 gene. The proliferation of RYR1 Variants of Uncertain Significance (VUS) on diagnostic genetic panels poses a significant clinical challenge, often leading to unnecessarily complex clinical concerns. We report the case of a 27-year-old African American female with a personal history of recurrent exertional rhabdomyolysis found to have a heterozygous RYR1 c.13230G>C p.(Glu4410Asp) variant. She later tested negative via the gold-standard Caffein–Halothane Contracture Test (CHCT). A negative CHCT test with an in silico Rare Exome Variant Ensemble Learner (REVEL) score of 0.171 meets the ClinGen MHS Variant Curation Expert Panel (VCEP) criteria for reclassification of the variant to Likely Benign. Additionally, the high allele frequency isolated within the African American (AA) population suggests a benign, ancestry-specific polymorphism maintained within the AA population rather than a pathogenic MHS mutation. Therefore, reclassifying the variant to Likely Benign prevents unnecessary muscle biopsies and alterations to perioperative anesthetic management and reduces the need for family cascade testing, and reduces use of potentially suboptimal alternative anesthetic protocols.

Read PDF

Similar papers

Open access Nov 2026

Expanding the clinical and geographical spectrum of PARK-LRRK2 p.(Asn1437His): first report in a Swiss family

INTRODUCTION: Pathogenic variants in the LRRK2 gene represent the most common monogenic cause of Parkinson’s disease. Individual variants differ in frequency, geographical distribution and genotype-phenotype associations. Here, we report a Swiss family with multiple affected individuals carrying a very rare ROC-domain...

Jacob Clausen, M. Sousa, Georg Kägi et al. · 0 citations
Open access Nov 2026

ClinGen Bayesian Framework-Based Interpretation and Functional Validation of a COL10A1 Missense Variant in a Patient With Skeletal Dysplasia.

Rare missense variants are difficult to interpret when phenotypes overlap and evidence is incomplete. We demonstrated the practical application of the ClinGen Bayesian framework for the interpretation of a COL10A1 missense variant identified in a Korean family with short stature across four generations. A 38-yr-old wom...

Ha-eun Cho, Sojin Yun, Seonbin Seo et al. · 0 citations
Review Open access Nov 2026

Systematic Reclassification of Variants of Uncertain Significance in a Clinical Nephrogenomics Program: Insights from the RAPIDS Collaboration

A structured, multidisciplinary VUS resolution workflow enabled considerable VUS reclassification, nearly doubling the diagnostic yield and improvements in diagnostic yield and clinical utility.

Tung-Lin Lee, Yao-Chun Zhang, Tina Si Ting Lim et al. · 0 citations
Open access Sep 2026

Functional Validation of a CC2D2A Non-Canonical Splice-Site Variant Supports Prenatal Molecular Testing in Joubert Syndrome

Background: Joubert syndrome (JS) is a genetically heterogeneous ciliopathy wherein non-canonical splice-site (NCSS) variants are frequently reported as variants of uncertain significance (VUS), complicating prenatal counseling. We aimed to clarify the clinical significance of an NCSS in CC2D2A through functional valid...

Fang Wang, J. Zhang, Chao Lu et al. · 0 citations
Open access Sep 2026

Population Frequency of RYR1 and CACNA1S Variants Associated with Malignant Hyperthermia in the Korean General Population: A KOVA Database Analysis

Background/Objectives: Malignant hyperthermia (MH) is a rare but life-threatening pharmacogenetic disorder. It is most often caused by variants in RYR1 and CACNA1S. The frequency of these variants differs across populations. However, no study has examined this in a general, unselected Korean population. Methods: We scr...

Jihyo Byon, Jimyeong Jeong · 0 citations
Open access 2026

Marked intrafamilial phenotypic variability of MYH7 p.Arg719Gln in a four-generation family with a history of multiple premature sudden deaths

Background: Hypertrophic cardiomyopathy (HCM) due to sarcomeric variants shows age-dependent penetrance and wide intrafamilial variability. The MYH7 p.Arg719Gln variant has been labelled “malignant,” a label current guidelines no longer support because genotype is excluded from validated sudden cardiac death (SCD) risk...

Mehdi Guedira, Hind Hibatouallah, J. Nguadi et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.